Key result
Immunization with one dose of FMD VLP produced in E. coli resulted in complete protection of guinea pigs, swine, and cattle from homologous FMDV challenge, with a 50% protection dose (PD50) of 6.34 in cattle.
Why the study?
Does FMD VLP immunization induce protective immune responses against FMDV in guinea pigs, swine, and cattle?
Does FMD VLP immunization induce protective immune responses against FMDV in guinea pigs, swine, and cattle?
Absolute Event Rate: 100% vs 0%
FMD VLP produced in E. coli is an effective vaccine candidate that provides complete protection against homologous FMDV challenge in guinea pigs, swine, and cattle.
May advance FMD control strategies in livestock; leaves open field efficacy, duration, and regulatory validation.
Foot-and-mouth disease virus (FMDV) causes a highly contagious infection in cloven-hoofed animals. The format of FMD virus-like particles (VLP) as a non-replicating particulate vaccine candidate is a promising alternative to conventional inactivated FMDV vaccines. In this study, we explored a prokaryotic system to express and assemble the FMD VLP and validated the potential of VLP as an FMDV vaccine candidate. VLP composed entirely of FMDV (Asia1/Jiangsu/China/2005) capsid proteins (VP0, VP1 and VP3) were simultaneously produced as SUMO fusion proteins by an improved SUMO fusion protein system in E. coli. Proteolytic removal of the SUMO moiety from the fusion proteins resulted in the assembly of VLP with size and shape resembling the authentic FMDV. Immunization of guinea pigs, swine and cattle with FMD VLP by intramuscular inoculation stimulated the FMDV-specific antibody response, neutralizing antibody response, T-cell proliferation response and secretion of cytokine IFN-γ. In addition, immunization with one dose of the VLP resulted in complete protection of these animals from homologous FMDV challenge. The 50% protection dose (PD50) of FMD VLP in cattle is up to 6.34. These results suggest that FMD VLP expressed in E. coli are an effective vaccine in guinea pigs, swine and cattle and support further development of these VLP as a vaccine candidate for protection against FMDV.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2013) studied Foot-and-mouth disease (n=45). Foot-and-mouth disease virus-like particles (FMD VLP) vs. PBS or healthy control was evaluated on Complete protection from homologous FMDV challenge. Immunization with one dose of FMD VLP produced in E. coli resulted in complete protection of guinea pigs, swine, and cattle from homologous FMDV challenge, with a 50% protection dose (PD50) of 6.34 in cattle.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: